Granules Pharmaceuticals Inc. recalls Trazodone Hydrochloride
- Published
- 11 Feb 2026
- Units affected
- 71424 bottles.
- Agency
- FDA
- Country
- United States
The hazard
Presence of Foreign Tablets/Capsules
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
- Brand / company
- Granules Pharmaceuticals Inc.
- Codes / lots
- Batch # 6160008A, Exp Date: 12/31/2026
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 11 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.